The endothelium plays an important role in the regulation of localized immune responses and trafficking of leukocytes in normal and diseased tissue. Microvascular endothelial cells, through the selective expression of cell adhesion molecules and cytokines, perform the crucial function as """"""""gatekeepers"""""""" of inflammation by controlling the physiological homing of leukocytes to specific immune compartments and modulating the abnormal recruitment of immune cells into inflamed tissues. The acquisition of fundamental knowledge regarding the role of vascular endothelium in mucosal immunity and inflammatory bowel disease (IBD) has been hindered by the lack of availability of these cells in vitro. To overcome this obstacle, we have developed a novel methodology to isolate, culture and study microvascular endothelial cells from normal and IBD-involved mucosa. These novel approach will be used to test the following central hypothesis: local activation of intestinal mucosal micro vascular endothelial cells plays a pivotal role in the inflammatory response of IBD. This hypothesis will be tested by three specific aims: 1) Define the phenotypic and functional characteristics of microvascular endothelial cells from normal and inflamed human intestinal mucosa. This will include their isolation, and phenotypic and functional characterization; 2) Investigate the mechanisms of mucosal endothelial cell activation by inflammatory mediators. This will include the evaluation of phenotypic, functional and molecular changes induced by cytokines, bacterial products and leukocyte interaction; 3) Explore the effect of oxidized lipids and lipoproteins on mucosal endothelial cell activation. This will determine which and how specific oxidized lipoproteins modulate the phenotypic and functional characteristics outlined in the previous aims. To achieve these goals, the Mentored Clinical Scientist Development Award will provide broad and essential training in laboratories dedicated to endothelial cell biology, mucosal immunity, regulation of activation genes, and biology of lipoproteins. This extended and formal training experience will lead to the acquisition of new expertise in unique areas outside of traditional IBD research, bringing a fresh new perspective to the understanding of the mechanisms of gut inflammation. Information generated by this project will help characterize a still unexplored population of mucosal cells, define fundamental alterations in endothelial- leukocyte interaction in IBD, and explore possible mechanisms linking dietary lipids to the initiation and maintenance of chronic mucosal inflammation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08DK002417-06
Application #
6175955
Study Section
Special Emphasis Panel (SRC)
Program Officer
Podskalny, Judith M
Project Start
1997-07-01
Project End
2002-03-31
Budget Start
2000-04-01
Budget End
2002-03-31
Support Year
6
Fiscal Year
2000
Total Cost
$122,040
Indirect Cost
Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Rafiee, Parvaneh; Ogawa, Hitoshi; Heidemann, Jan et al. (2003) Isolation and characterization of human esophageal microvascular endothelial cells: mechanisms of inflammatory activation. Am J Physiol Gastrointest Liver Physiol 285:G1277-92
Rafiee, Parvaneh; Johnson, Christopher P; Li, Mona S et al. (2002) Cyclosporine A enhances leukocyte binding by human intestinal microvascular endothelial cells through inhibition of p38 MAPK and iNOS. Paradoxical proinflammatory effect on the microvascular endothelium. J Biol Chem 277:35605-15
Chai, Yuh-Cherng; Binion, David G; Macklis, Roger et al. (2002) Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix. Vascul Pharmacol 38:229-37
Binion, D G; Rafiee, P; Ramanujam, K S et al. (2000) Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Radic Biol Med 29:881-8
Binion, D G; Fu, S; Ramanujam, K S et al. (1998) iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol 275:G592-603
Binion, D G; West, G A; Volk, E E et al. (1998) Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease. Lancet 352:1742-6
Binion, D G; West, G A; Ina, K et al. (1997) Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology 112:1895-907